GLENMARK PHARMACEUTICALS EUROPE R&D LIMITED

LAXMI HOUSE 2-B DRAYCOTT AVENUE, KENTON, HARROW  HA3 0BU
  • Active - Proposal to Strike off
  • Private Limited Company
  • Company No. 06420547
  • Last Updated: 01 Dec 2021

Company Profile

GLENMARK PHARMACEUTICALS EUROPE R&D LIMITED was incorporated on Wednesday, November 7, 2007 as a Private Limited Company with registered address in HARROW. GLENMARK PHARMACEUTICALS EUROPE R&D LIMITED has the status: Active - Proposal to Strike off and it's listed in the following category: Research and experimental development on biotechnology. This Private Limited Company has been operating for 17 years 3 months and 15 days.

Name GLENMARK PHARMACEUTICALS EUROPE R&D LIMITED
Company number 06420547
Company type Private Limited Company
Incorporation date 07 Nov 2007
Status Active - Proposal to Strike off
Industry (SIC 2007)

Address

Registered Address LAXMI HOUSE 2-B DRAYCOTT AVENUE
KENTON
HARROW
HA3 0BU
Country Of Origin

Map based on PostCode

Ownership Information

Individuals and organizations with significant control over the business either by owning at least 25% shares or by virtue of significant influence over the business.

Name Nature of Control
Mr Glenn Saldanha Nationality: Indian Dates: Wednesday, April 6, 2016 - present
significant influence or control
Ms Blanche Elizabeth Saldanha Nationality: Indian Dates: Wednesday, April 6, 2016 - present
ownership of shares 25 to 50 percent as trust
Mrs Cherylann Pinto Nationality: Indian Dates: Wednesday, April 6, 2016 - present
ownership of shares 25 to 50 percent as trust

Accounts and Confirmation

Type of accounts SMALL
End of financial Year 31 March
Next annual accounts due 31 December 2021, (-1149 days left)
Latest accounts 31 March 2020
Next confirmation statement due 05 December 2016
Last confirmation statement dated 07 November 2015

Mortgages

No mortgages have been registered against GLENMARK PHARMACEUTICALS EUROPE R&D LIMITED.

Previous Names

Name Change Date
GLENMARK PHARMACEUTICALS EUROPE R&D LIMITED 07 Nov 2007
NEWINCCO 778 LIMITED 15 Jan 2008
GLENMARK PHARMACEUTICALS EUROPE LIMITED 29 Nov 2013